CRAMS
Contract Research & Manufacturing Services (CRAMS)
The global market for Contract Research and Manufacturing Services (CRAMS) Global Report valued the CRAMS industry at US$138.9 Billion in 2024 and is projected to reach US$211.4 Billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030. Only companies with the most advanced pharmaceutical manufacturing technology will be able to compete in the growing CRAMS market.
Dr. Ashleys is a global leader in Contract Research and Manufacturing Services (CRAMS). Through our advanced technology and 13 low cost manufacturing patents, Dr. Ashleys is ideally positioned to provide comprehensive support for R&D programs, from process development to full-scale realization, driving innovation and progress in the pharmaceutical industry.
Technology transfer
Dr. Ashleys Advanced Technology Transfer services ensure seamless transition from development to commercial production. We meticulously manage the transfer of knowledge, processes, and technologies to guarantee consistent quality and efficiency in manufacturing.
Manufacturing Process Engineering & Design
The Manufacturing Process Engineering & Design team at Dr. Ashleys excels in creating innovative and efficient production processes. We focus on optimizing manufacturing workflows to enhance productivity, reduce costs, and maintain the highest standards of quality.
